{"name":"Dafna Capital Management","permalink":"dafna-capital-management","crunchbase_url":"http://www.crunchbase.com/financial-organization/dafna-capital-management","homepage_url":"http://www.dafnacapital.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"310.954.3200","description":"Venture Capital Firm","email_address":"","number_of_employees":null,"founded_year":1999,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jul 07 09:18:16 UTC 2010","updated_at":"Sat Sep 11 11:54:58 UTC 2010","overview":"<p>DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment adviser, was established in 1999.</p>\n\n<p>DAFNA specializes in managing long/short portfolios of predominately publicly traded biotechnology and medical device companies and currently utilizes three different long/short investment strategies. DAFNA performs detailed fundamental analysis and disciplined risk management.</p>","image":{"available_sizes":[[[150,59],"assets/images/resized/0010/1343/101343v1-max-150x150.jpg"],[[170,67],"assets/images/resized/0010/1343/101343v1-max-250x250.jpg"],[[170,67],"assets/images/resized/0010/1343/101343v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"HQ","address1":"10990 Wilshire Boulevard","address2":"Suite 1400 ","zip_code":"90024","city":"Los Angeles","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.dorbiopharma.com/news.aspx?titleId=351","source_description":"Soligenix Announces Private Equity Financing of $5.16 Million with its Partner Sigma-Tau and other Institutional Investors","raised_amount":5160000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":16,"company":{"name":"Soligenix","permalink":"soligenix","image":{"available_sizes":[[[150,42],"assets/images/resized/0009/2621/92621v1-max-150x150.jpg"],[[250,70],"assets/images/resized/0009/2621/92621v1-max-250x250.jpg"],[[357,100],"assets/images/resized/0009/2621/92621v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.raptorpharma.com/phoenix.zhtml?c=198466&p=irol-newsArticle&ID=1458272&highlight=","source_description":"Raptor Pharmaceutical Announces Pricing of $15 Million PIPE Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":9,"company":{"name":"Raptor Pharmaceuticals","permalink":"raptor-pharmaceuticals","image":{"available_sizes":[[[150,45],"assets/images/resized/0010/8069/108069v1-max-150x150.png"],[[233,70],"assets/images/resized/0010/8069/108069v1-max-250x250.png"],[[233,70],"assets/images/resized/0010/8069/108069v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.oncothyreon.com/releasedetail.cfm?ReleaseID=510806","source_description":" Oncothyreon Announces Pricing of $14.9 Million Private Placement","raised_amount":14900000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":24,"company":{"name":"Oncothyreon","permalink":"oncothyreon","image":{"available_sizes":[[[150,36],"assets/images/resized/0010/0796/100796v1-max-150x150.png"],[[250,60],"assets/images/resized/0010/0796/100796v1-max-250x250.png"],[[324,79],"assets/images/resized/0010/0796/100796v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}